Nemaura Medical (NMRD) SugarBEAT Study Show Positive Results in European Clinical Program

January 31, 2018 1:23 PM EST Send to a Friend
Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing the wireless sugarBEAT® non-invasive glucose monitoring system for adjunctive use ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login